Close Menu

antibodies

New Products: Feb 26, 2009

Premium

Agilent, GWC Technologies, Pall Life Sciences, AnaSpec

Millipore said that the technology will be used to develop a range of new multiplex immunoassay kits that can be used with the Luminex xMAP platform.

The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

Not That Kind of ESP

Premium

Harvard researchers have built a computational tool that they believe could help get more protein biomarkers into clinical use.

The firms will combine Innovative Biosensors' antibody technology with ProGenTech's Enture Lite platform to create a rapid diagnostic system.

News Scan: Feb 20, 2009

Premium

GeneGo, Millipore, DiscoveryBioMed, Lifeline Cell Technology

New Products: Feb 19, 2009

Premium

Olink Biosciences

Included is a paper on the use of a mass spectrometry-based strategy for the absolute quantification of protein complex components, one using SISCAPA technology, and one showing that top-down proteomics can be done using CID on a q-TOF instrument.

Both companies separately last week announced plans to expand the scope of their respective businesses in response to what they said is increased desire from customers to outsource their array production and array-based research projects.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.